Drugs Approved for Soft Tissue Sarcoma

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for soft tissue sarcoma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in soft tissue sarcoma that are not listed here.

Drugs Approved for Soft Tissue Sarcoma

Cosmegen (Dactinomycin)
Dactinomycin
Doxorubicin Hydrochloride
Eribulin Mesylate
Gleevec (Imatinib Mesylate)
Halaven (Eribulin Mesylate)
Imatinib Mesylate
Lartruvo (Olaratumab)
Olaratumab
Pazopanib Hydrochloride
Trabectedin
Votrient (Pazopanib Hydrochloride)
Yondelis (Trabectedin)

Drugs Approved for Soft Tissue Sarcoma

Drugs Approved for Soft Tissue Sarcoma

Drug Combinations Used in Soft Tissue Sarcoma